ALPS Group Inc Ordinary Share (NASDAQ:ALPS) Sees Large Growth in Short Interest

ALPS Group Inc Ordinary Share (NASDAQ:ALPS) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totaling 124,227 shares, an increase of 264.0% from the August 31st total of 34,125 shares. Currently, 0.1% of the company’s shares are short sold. Based on an average daily volume of 63,432 shares, the short-interest ratio is presently 2.0 days.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in ALPS Group Inc Ordinary Share stock. SkyView Investment Advisors LLC lifted its holdings in ALPS Group Inc Ordinary Share (NASDAQ:ALPS) by 1,000.0% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 110,000 shares of the company’s stock after buying an additional 100,000 shares during the period. SkyView Investment Advisors LLC owned approximately 0.07% of ALPS Group Inc Ordinary Share worth $64,000 at the end of the most recent reporting period. 27.90% of the stock is currently owned by hedge funds and other institutional investors.

ALPS Group Inc Ordinary Share Stock Down 1.0%

Shares of ALPS Group Inc Ordinary Share stock traded down $0.00 during trading hours on Friday, reaching $0.40. The company’s stock had a trading volume of 69,697 shares, compared to its average volume of 59,054. The business has a fifty day simple moving average of $0.39. The stock has a market cap of $65.89 million, a P/E ratio of 1.20 and a beta of -0.10. ALPS Group Inc Ordinary Share has a one year low of $0.23 and a one year high of $15.00.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of ALPS Group Inc Ordinary Share in a research note on Monday, July 6th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has an average rating of “Sell”.

About ALPS Group Inc Ordinary Share

ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.